Bmi1 Resistance Pathway and Immune Checkpoint Blockade in Lung Cancer

被引：0
|
作者：
Chaudhary, K. R. [1 ]
Halmos, B. [2 ,3 ]
Cheng, H. [2 ,3 ]
Cheng, S. K. [1 ,4 ]
机构：
[1] Columbia Univ, Irving Med Ctr, Dept Radiat Oncol, New York, NY USA
[2] Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[4] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2893
引用
收藏
页码：E432 / E433
页数：2
相关论文
共 50 条
  • [41] The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System
    Moon, Edmund K.
    Langer, Corey J.
    Albelda, Steven M.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (08) : 1248 - 1260
  • [42] The cutting-edge progress of immune-checkpoint blockade in lung cancer
    Zhou, Fei
    Qiao, Meng
    Zhou, Caicun
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (02) : 279 - 293
  • [43] Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?
    Paglialunga, Luca
    Salih, Zena
    Ricciuti, Biagio
    Califano, Raffaele
    [J]. ESMO OPEN, 2016, 1 (04)
  • [44] Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy
    Huang, Jumin
    Jiang, Zebo
    Wang, Yuwei
    Fan, Xiaoqing
    Cai, Jun
    Yao, Xiaojun
    Liu, Liang
    Huang, Jun
    He, Jianxing
    Xie, Chun
    Wu, Qibiao
    Cao, Yabing
    Leung, Elaine Lai-Han
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 1 - 10
  • [45] Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer
    Zhao, Jun
    Xiao, Zhilan
    Li, Tingting
    Chen, Huiqin
    Yuan, Ying
    Wang, Y. Alan
    Hsiao, Cheng-Hui
    Chow, Diana S-L.
    Overwijk, Willem W.
    Li, Chun
    [J]. ACS NANO, 2018, 12 (10) : 9881 - 9893
  • [46] MECHANISMS OF LUNG CANCER HYPER-PROGRESSION PROMOTED BY PD-1 IMMUNE CHECKPOINT BLOCKADE
    Martinez-Usatorre, A.
    Kadioglu, E.
    Cianciaruso, C.
    Torchia, B.
    Faget, J.
    Meylan, E.
    Schmittnaegel, M.
    Keklikoglou, I.
    De Palma, M.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A5 - A5
  • [47] Anti-PD-1 Immune Checkpoint Blockade for Head and Neck Cancer Biomarkers of Response and Resistance
    Maroun, Christopher A.
    Mandal, Rajarsi
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2021, 54 (04) : 751 - 759
  • [48] A review of immune checkpoint blockade in breast cancer
    Pellegrino, Benedetta
    Tommasi, Chiara
    Cursio, Olga Elisabetta
    Musolino, Antonino
    Migliori, Edoardo
    De Silva, Pushpamali
    Senevirathne, Thilini Hemali
    Schena, Marina
    Scartozzi, Mario
    Farci, Daniele
    Willard-Gallo, Karen
    Solinas, Cinzia
    [J]. SEMINARS IN ONCOLOGY, 2021, 48 (03) : 208 - 225
  • [49] Gastric Cancer in the Era of Immune Checkpoint Blockade
    Figueroa-Protti, Lucia
    Soto-Molinari, Rebeca
    Calderon-Osorno, Melany
    Mora, Javier
    Alpizar-Alpizar, Warner
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [50] Immune Checkpoint Blockade in Breast Cancer Therapy
    Bu, Xia
    Yao, Yihui
    Li, Xiaoyu
    [J]. TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 383 - 402
12345